Eli Lilly Fights To Challenge Teva Migraine IP Despite Deal
Eli Lilly urged a London judge on Thursday to rule that a license agreement it reached with Teva Pharmaceuticals over its patents for a migraine treatment doesn't stop it from now...To view the full article, register now.
Already a subscriber? Click here to view full article